Award
National Cancer Institute 11210536
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
Recipient
University of California-Irvine
Award Amount
$82,514.00
Ceiling
$82,514.00
Awarded
August 25, 2025
Identifier
11210536
Award for research on mitigating cisplatin-induced neurotoxicity via targeting p38/JNK MAPK pathways, funded by the National Cancer Institute, led by University of California-Irvine.
Description
Research project focused on neurotoxicity related to cisplatin in ovarian cancer, emphasizing p38 MAPK and JNK pathways, funded by the National Cancer Institute with translational potential and impact on women's health.